These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16429832)

  • 61. Deals landscape: notable deals in the pharmaceutical industry in the third quarter of 2008.
    Glah D; Tear S
    IDrugs; 2008 Nov; 11(11):841-5. PubMed ID: 19024888
    [No Abstract]   [Full Text] [Related]  

  • 62. [MECHANIZED UNLOADING OF PENICILLIN MYCELIA FROM DRUM VACUUM FILTERS (FROM INDUSTRIAL PRACTICE)].
    RUMIANTSEV VI; KULKOV NG; SLUSHKIN MI
    Med Prom SSSR; 1963 Nov; 17():56-7. PubMed ID: 14134149
    [No Abstract]   [Full Text] [Related]  

  • 63. The economic impact of clean indoor air laws.
    Eriksen M; Chaloupka F
    CA Cancer J Clin; 2007; 57(6):367-78. PubMed ID: 17989131
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The common future of urology and the pharmaceutical industry].
    Odenthal G
    Urologe A; 2006 Sep; 45 Suppl 4():41-3. PubMed ID: 16955325
    [No Abstract]   [Full Text] [Related]  

  • 65. Pharmaceutical industry financial performance.
    Goodman M
    Nat Rev Drug Discov; 2009 Dec; 8(12):927-8. PubMed ID: 19949398
    [No Abstract]   [Full Text] [Related]  

  • 66. [Dessication: fundamental principles and practical applications in the pharmaceutical industry].
    Bellentani L
    Farmaco Prat; 1966 Sep; 21(9):463-84. PubMed ID: 5994442
    [No Abstract]   [Full Text] [Related]  

  • 67. A quantitative integrated assessment of pollution prevention achieved by integrated pollution prevention control licensing.
    Styles D; O'Brien K; Jones MB
    Environ Int; 2009 Nov; 35(8):1177-87. PubMed ID: 19709749
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Estimates of associated outdoor particulate matter health risk and costs reductions from alternative building, ventilation and filtration scenarios.
    Sultan ZM
    Sci Total Environ; 2007 May; 377(1):1-11. PubMed ID: 17346775
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Endotoxins in tobacco smoke: shifting tobacco industry positions.
    Barnes RL; Glantz SA
    Nicotine Tob Res; 2007 Oct; 9(10):995-1004. PubMed ID: 17852769
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [A new orientation to the pharmacy compounding in Belgium].
    Delattre L
    J Pharm Belg; 2003; 58(4):85-8. PubMed ID: 14753106
    [No Abstract]   [Full Text] [Related]  

  • 71. The value of drug repositioning in the current pharmaceutical market.
    Tobinick EL
    Drug News Perspect; 2009 Mar; 22(2):119-25. PubMed ID: 19330170
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Drug supply chain safety in hospitals: current data and experience of the Grenoble university hospital].
    Bedouch P; Baudrant M; Detavernier M; Rey C; Brudieu E; Foroni L; Allenet B; Calop J
    Ann Pharm Fr; 2009 Jan; 67(1):3-15. PubMed ID: 19152845
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Strategic profile of a firm operating in the pharmaceutical field].
    Rotondi V
    Boll Chim Farm; 1987 Jan; 126(1):3-19. PubMed ID: 3270399
    [No Abstract]   [Full Text] [Related]  

  • 74. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
    Peppercorn J; Blood E; Winer E; Partridge A
    Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A changing drug supply.
    Nature; 2007 Feb; 445(7127):460. PubMed ID: 17268432
    [No Abstract]   [Full Text] [Related]  

  • 76. Production of plasmid DNA for pharmaceutical use.
    Voss C
    Biotechnol Annu Rev; 2007; 13():201-22. PubMed ID: 17875478
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
    Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
    Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
    [No Abstract]   [Full Text] [Related]  

  • 78. Brazil: An emerging partner in drug R&D.
    Rodrigues DG
    IDrugs; 2009 Aug; 12(8):497-502. PubMed ID: 19629884
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmaceutical GMP: past, present, and future--a review.
    Patel KT; Chotai NP
    Pharmazie; 2008 Apr; 63(4):251-5. PubMed ID: 18468382
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Meeting commentary--formulating better medicines for children.
    Hempenstall J; Tuleu C
    Int J Pharm; 2009 Sep; 379(1):143-5. PubMed ID: 19576979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.